Integra LifeSciences Q3 Adjusted Earnings, Revenue Rise

06:35 AM EDT, 10/21/2026 (MT Newswires) -- Integra LifeSciences (IART) reported Q3 adjusted earnings Wednesday of $0.59 per diluted share, up from $0.54 a year earlier. Analysts surveyed by FactSet expected $0.56. Net revenue for the quarter ended Sept. 30 was $411.2 million, up from $402.1 million a year earlier. Analysts expected $413.2 million. For Q4, the company expects adjusted EPS of $0.61 to $0.71 on revenue of $413 million to $433 million. Analysts are looking for $0.74 and $434.6 million, respectively. For 2026, Integra LifeSciences continues to expect adjusted EPS of $2.30 to $2.40 on revenue of $1.63 billion to $1.65 billion. Analysts are looking for $2.40 and $1.66 billion, respectively.